| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.74 | 0.005 | 0.74 | 5 Hydroxytryptamine release stimulant | 0.447 0.037 DBMET00383 | ||
| 0.718 | 0.005 | 0.718 | Spasmolytic | 0.408 0.038 DBMET00383 | ||
| 0.67 | 0.004 | 0.67 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 DBMET00383 | ||
| 0.492 | 0.009 | 0.492 | P-glycoprotein inhibitor | 0.339 0.023 DBMET00383 | ||
| 0.457 | 0.004 | 0.457 | Nav1.6 sodium channel blocker | 0.19 0.023 DBMET00383 | ||
| 0.457 | 0.02 | 0.457 | Cardiotonic | 0.39 0.03 DBMET00383 | ||
| 0.388 | 0.005 | 0.388 | Nav1.3 sodium channel blocker | 0.116 0.078 DBMET00383 | ||
| 0.372 | 0.005 | 0.372 | Nav1.1 sodium channel blocker | 0.228 0.014 DBMET00383 | ||
| 0.37 | 0.005 | 0.37 | Acetylcholine nicotinic antagonist | 0.105 0.036 DBMET00383 | ||
| 0.411 | 0.072 | 0.411 | Antibacterial | 0.309 0.128 DBMET00383 | ||
| 0.328 | 0.005 | 0.328 | Neuronal nicotinic receptor antagonist | 0.083 0.034 DBMET00383 | ||
| 0.271 | 0.015 | 0.271 | Aldehyde dehydrogenase inhibitor | |||
| 0.273 | 0.018 | 0.273 | Nav1.2 sodium channel blocker | |||
| 0.248 | 0.029 | 0.248 | Cholinergic | |||
| 0.197 | 0.033 | 0.197 | Cholinergic antagonist | 0.156 0.049 DBMET00383 | ||
| 0.195 | 0.032 | 0.195 | Acetylcholine antagonist | 0.153 0.048 DBMET00383 | ||
| 0.301 | 0.171 | 0.301 | Apoptosis agonist | |||
| 0.172 | 0.043 | 0.172 | Neurotrophic factor | 0.142 0.067 DBMET00383 | ||
| 0.208 | 0.1 | 0.208 | MAP kinase kinase 3 inhibitor | 0.2 0.123 DBMET00383 | ||
| 0.104 | 0.004 | 0.104 | Acid-sensing ion channel blocker | 0.054 0.013 DBMET00383 | ||
| 0.097 | 0.012 | 0.097 | Dopamine transporter inhibitor | 0.048 0.034 DBMET00383 | ||
| 0.127 | 0.047 | 0.127 | Nav1.5 sodium channel blocker | |||
| 0.096 | 0.022 | 0.096 | Acetylcholine M2 receptor antagonist | |||
| 0.095 | 0.028 | 0.095 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.126 | 0.061 | 0.126 | Acetylcholine muscarinic antagonist | 0.104 0.085 DBMET00383 | ||
| 0.083 | 0.025 | 0.083 | Adrenaline uptake inhibitor | 0.067 0.038 DBMET00383 | ||
| 0.057 | 0.013 | 0.187 | Squalene synthetase inhibitor | 0.187 0.003 DBMET00383 | DBMET00383 | |
| 0.072 | 0.028 | 0.072 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.042 | 0.01 | 0.042 | HCV polyprotein inhibitor | |||
| 0.059 | 0.03 | 0.059 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.041 | 0.02 | 0.041 | Nicotinic acid receptor 2 agonist | |||
| 0.056 | 0.04 | 0.056 | Potassium channel Kv1.5 blocker | |||
| 0.036 | 0.024 | 0.037 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.037 0.023 DBMET00383 | DBMET00383 | |
| 0.047 | 0.041 | 0.047 | 5 Hydroxytryptamine 2 agonist | |||
| 0.077 | 0.07 | 0.219 | Antineoplastic alkaloid | 0.219 0.009 DBMET00383 | DBMET00383 | |
| 0.052 | 0.047 | 0.052 | Dopamine uptake inhibitor | |||
| 0.068 | 0.064 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.127 | 0.125 | 0.127 | MAP kinase kinase 4 inhibitor | |||
| 0.121 | 0.12 | 0.132 | Growth hormone agonist | 0.132 0.104 DBMET00383 | DBMET00383 | |
| 0.034 | 0.035 | 0.038 | Substance P antagonist | 0.038 0.03 DBMET00383 | DBMET00383 | |
| 0.191 | 0.194 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.179 DBMET00383 | DBMET00383 | |
| 0.117 | 0.142 | 0.127 | Nitric oxide antagonist | 0.127 0.123 DBMET00383 | DBMET00383 | |
| 0.212 | 0.303 | 0.262 | Caspase 9 stimulant | 0.262 0.239 DBMET00383 | DBMET00383 | |
| 0.083 | 0.249 | 0.493 | Hypolipemic | 0.493 0.013 DBMET00383 | DBMET00383 | |
| 0.083 | 0.376 | 0.197 | Hypoxia-inducible factor 1 alpha inhibitor | 0.197 0.156 DBMET00383 | DBMET00383 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |